Disease burden and predictors associated with non-response to antihistamine-based therapy in chronic spontaneous urticaria
Weily Soong, Dhaval Patil, Irina Pivneva, James Signorovitch, Michael A. Wells, Maria-Magdalena Balp, Merin Kuruvilla · 2023
Read Disease burden and predictors associated with non-response to antihistamine-based therapy in chronic spontaneous urticaria by Weily Soong, Dhaval Patil, Irina Pivneva, James Signorovitch, Michael A. Wells, Maria-Magdalena Balp, Merin Kuruvilla (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10701591.txt.
Description
Weily Soong and co-authors study why standard allergy drugs fail many people with chronic hives, in a 2023 paper. The condition, chronic spontaneous urticaria, brings itchy welts with no clear trigger. Antihistamines are the first treatment, yet about half of patients stay poorly controlled at normal doses. The team asked who fails to respond and what extra burden they carry.
Using a large health record data set, they split adults by their treatment path over a year. Patients who kept needing steroids or switched drugs often counted as non-responders. Most patients in the data fell into that group. Machine learning then hunted for early traits that predict non-response. Such forecasts could steer hard cases to stronger care sooner.
Catalog record
| CREATOR | Weily Soong, Dhaval Patil, Irina Pivneva, James Signorovitch, Michael A. Wells, Maria-Magdalena Balp, Merin Kuruvilla |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |